160 HEALTH (02656) announced a profit warning, expecting a mid-term net profit of approximately 1 million to 3 million yuan, turning a profit compared to the same period last year.

160 HEALTH (02656) announced that the Group expects to achieve a net profit of approximately RMB 1 million to 3 million for the six months ending June 30, 2026, compared to a loss of RMB 19.6 million for the six months ending June 30, 2025 (the same period last year). The Group's operational performance during the reporting period has significantly improved compared to the same period last year, resulting in a turnaround from loss to profit, primarily due to the continued optimization of the business structure during the reporting period. During this period, the number of hospitals operating in cooperation with "160AI" saw rapid growth, which in turn led to a steady increase in the number of paid cooperative healthcare institutions, driving overall revenue growth in the high-margin sector of digital medical health solutions. As a result, the Group's gross profit increased by approximately RMB 20 million to 24 million year-on-year during the reporting period, reflecting a growth of about 31.2% to 37.5% compared to the same period last year.